Press Releases

May 23, 2022 8:30am EDT

Kuick Research Recognizes TC BioPharm as a Key Player in the Gamma-Delta T Cell Therapy Market

May 18, 2022 8:30am EDT

TC BioPharm Announces Formation of Scientific Advisory Board with Renowned Cell Therapy Experts

May 03, 2022 8:30am EDT

TC BioPharm Invited to Present at LD Micro Conference

Apr 26, 2022 8:45am EDT

TC BioPharm to Participate in Upcoming Conferences

Apr 21, 2022 8:00am EDT

TC BioPharm Donates to Leukemia and Lymphoma Society in Sponsorship of World AML Day

Apr 06, 2022 8:30am EDT

TC BioPharm Receives CryoTC® Trademark for Proprietary Cell Freezing Process

Mar 29, 2022 8:30am EDT

TC BioPharm Announces Initiation of Equity Analyst Coverage by EF Hutton with a "Buy" Recommendation

Mar 23, 2022 8:30am EDT

TC BioPharm Receives MHRA and Research Ethics Committee Approvals to Initiate Phase 2B/3 Clinical Trials for the Treatment of Acute Myeloid Leukemia

Mar 17, 2022 8:30am EDT

TC BioPharm Announces FDA Orphan Drug Status Granted for OmnImmune®

Mar 15, 2022 8:30am EDT

TC Biopharm Updates Intellectual Property Portfolio

rss_feed News RSS

This website stores cookies on your computer. These cookies, which also could include third party cookies, are used (among other purposes) to improve the website and provide more personalized services to you. To find out more about how we use cookies and how to change your settings, see our Privacy Policy.

I Accept